Gates Foundation backs CureVac with $52m, Hopp invests $24m

The Bill & Melinda Gates Foundation made its largest-ever equity investment in a biotechnology company when it committed $52m to the continued development of Tubingen, Germany-based CureVac's novel vaccines and construction of manufacturing facilities.